A new trial has been launched in Oxford to test multiple new treatments for patients with hip fractures. Take out a digital subscription today and you'll get unlimited access to all our articles, ...
The Association of periOperative Registered Nurses (AORN) and Pfiedler Education will host the Southeast Reconstruction Summit on Nov. 22, 2025, at The Hotel at Avalon in Alpharetta, Georgia. This one ...
Disparate scheduling policies, manual workflows and limited real-time visibility constrained operating room efficiency at Columbia, Md.-based ...
Pembrolizumab (Keytruda) administered before and after surgery reduced the risk of death by 26% vs placebo in patients with early-stage non–small cell lung cancer (NSCLC), according to 5-year ...
After years of campaigning on public health and prevention, the Royal College of Physicians (RCP) welcomed government making the shift from ‘sickness to prevention’ one of its three major priorities ...
Every year, thousands of families sit in hospital rooms hearing words no one wants to hear: "We have done everything we can." ...
Data from NIAGARA supported the FDA’s approval of neoadjuvant durvalumab in combination with gemcitabine and cisplatin, ...
Nathaniel Hughes, 40, played wide receiver on four N.F.L. teams including the Jacksonville Jaguars and Detroit Lions. He was ...
MedPage Today on MSN
'Remarkable' Survival Outcomes in Cisplatin-Ineligible Bladder Cancer
The perioperative enfortumab vedotin plus pembrolizumab (EV-P) substantially increased the frequency of adverse events (AEs), ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Excessive Daytime Sleepiness (EDS) in older adults (60+) who undergone non-cardiac surgery is linked to a greater cognitive ...
Serplulimab significantly improved event-free survival in gastric cancer, showing potential as a neoadjuvant/adjuvant monotherapy. The combination with chemotherapy achieved a pathologic complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results